Actively Recruiting
Krabbe Disease Global Patient Registry
Led by State University of New York at Buffalo · Updated on 2025-02-10
60
Participants Needed
1
Research Sites
626 weeks
Total Duration
On this page
Sponsors
S
State University of New York at Buffalo
Lead Sponsor
R
Rare Diseases Clinical Research Network
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to develop a clinical database of individuals diagnosed with Krabbe disease in order to determine which symptoms herald the onset of clinical disease in the various phenotypes of Krabbe disease; to determine whether level of GALC enzyme activity, or a specific genetic mutation predict the clinical course; and to determine which neurodiagnostic tests predict onset and/or severity of the disease.
CONDITIONS
Official Title
Krabbe Disease Global Patient Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Anyone diagnosed with Krabbe disease
- Anyone at-risk for Krabbe disease
- Family members of someone diagnosed with, or at-risk for, Krabbe disease
You will not qualify if you...
- Anyone who is not diagnosed with, or at-risk for, Krabbe disease
- Anyone who is not a family member of someone diagnosed with, or at-risk for, Krabbe disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
State University of New York at Buffalo
Buffalo, New York, United States, 14203
Actively Recruiting
Research Team
T
Thomas J. Langan, MD
CONTACT
A
Amy Barczykowski
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here